Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. “I’m feeling well and symptom free,” Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid. Paxlovid is an antiviral medication that is… Read More Pfizer CEO Albert Bourla tests positive for coronavirus
The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a broad fall vaccination campaign that could begin within days. The new vaccines also include the original version of the virus targeted by all… Read More U.S. FDA approves coronavirus vaccines engineered for Omicron variant
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech U.S.-listed shares were down about 1.5% and Moderna shares slipped 1.7%… Read More Moderna files lawsuit against Pfizer/BioNTech for patent infringement over coronavirus vaccine
Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine retooled to target the Omicron variant. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant BA.4/BA.5 variants of the virus along with the original coronavirus strain. It is intended… Read More Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant
Pfizer Inc is boosting its pipeline with a $5.4 billion deal for blood disorder drugmaker Global Blood Therapeutics, the latest in a series of acquisitions to combat a potential slowdown in COVID-19 products demand as cases fall. Pfizer said on Monday it will pay $68.50 per share, representing a premium of 7.3% to Global Blood… Read More Pfizer acquires Global Blood Therapeutics in $5.4billion deal
Pfizer Inc and its German partner BioNTech SEsaid on Wednesday they had started a mid-stage study of a modified COVID-19 vaccine which targets both the original as well as the BA.2 Omicron subvariant. Pfizer said the vaccine is in an initial proof-of-concept study to gather more data. Together, the BA.4 and BA.5 subvariants are estimated… Read More Pfizer begins mid-stage trial for vaccine against coronavirus Omicron subvariant
Joe Biden, the oldest person ever to serve as president of the United States, has tested positive for COVID-19, is experiencing mild symptoms and will continue working but in isolation, the White House said on Thursday. Biden, 79, has a runny nose, fatigue and an occasional dry cough, symptoms which he began to experience late… Read More U.S. President Joe Biden tests positive for coronavirus
People in the UK who are at increased risk of COVID-19 can now participate in the study of the first antiviral tablet for this virus that can be taken at home, while those who are classified as particularly susceptible can receive antibody infusions as soon as they test positive. Doctors had no therapies for COVID-19… Read More The UK has begun to use medications to treat COVID-19 instances before they become serious
247NEWSUPDATE BLOG 